AORT
Artivion Inc
NYSE: AORT · HEALTHCARE · MEDICAL DEVICES
$34.64
-4.65% today
Updated 2026-04-29
Market cap
$1.68B
P/E ratio
164.95
P/S ratio
3.81x
EPS (TTM)
$0.21
Dividend yield
—
52W range
$23 – $48
Volume
0.4M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
6.7
Growth
B5.0
Quality
C+4.5
Profitability
C2.7
Valuation
F—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$51.57
+48.87%
12-Month target
$1.43
-95.87%
Intrinsic (DCF)
$35.30
Margin of safety
-13.60%
2 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 19.20% QoQ
Risks
- Thin margins at 2.21%
- Negative free cash flow $-7.95M
- 13.60% above intrinsic value
- P/E 164.95x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $313.79M | $354.00M | $388.54M | $441.33M | $441.33M |
| Net income | $-19.19M | $-30.69M | $-13.36M | $9.77M | $2.43M |
| EPS | — | — | — | — | $0.21 |
| Free cash flow | $-15.87M | $11.39M | $11.05M | $-911000.00 | $-7.95M |
| Profit margin | -6.12% | -8.67% | -3.44% | 2.21% | 2.21% |
Peer comparison
Smart narrative
Artivion Inc trades at $34.64. representing a P/E of 164.95x trailing earnings. Our Smart Value Score of 39/100 indicates the stock is weak. TTM revenue stands at $441.33M. with profit margins at 2.21%. Our DCF model estimates intrinsic value at $35.30.
Frequently asked questions
What is Artivion Inc's stock price?
Artivion Inc (AORT) trades at $34.64.
Is Artivion Inc overvalued?
Smart Value Score 39/100 (Grade D, Sell). DCF value $35.30.
What is the price target of Artivion Inc (AORT)?
The analyst target price is $51.57, representing +48.9% upside from the current price of $34.64.
What is the intrinsic value of Artivion Inc (AORT)?
Based on our DCF model, intrinsic value is $35.30, a -13.6% margin of safety versus $34.64.
What is Artivion Inc's revenue?
TTM revenue is $441.33M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.81x
ROE2.70%
Beta1.62
50D MA$36.72
200D MA$40.59
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—